Market News & Trends
Lightlake Therapeutics Joint Clinical Trial With NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose to be Promising
Lightlake Therapeutics Inc. recently announced the initial findings of its clinical trial with the National Institute on Drug Abuse (NIDA), part of the National Institutes…
Adocia Signs Exclusive Nanotechnology License
Adocia recently announced the signature of an exclusive license agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science…
Monoclonal Antibodies Market for Colorectal Cancer to Witness Moderate Growth, as Late-Stage Pipeline Remains Weak
The market value for monoclonal antibodies (mAbs) in colorectal cancer treatment will experience a moderate increase from $3.7 billion in 2012 to $5.2 billion by…
Antitope Enters Research Agreement with Annexon to Generate Novel Therapeutic Antibodies
Antitope Ltd recently announced it has entered a research agreement with Annexon to generate novel antibody therapeutics for the treatment of neurodegenerative diseases. Under the…
Peptineo Inks Exclusive Option for Drug Delivery Technologies
Peptineo recently announced the company has inked an exclusive option for a broad set of nanotechnology patents in the area of drug delivery from Lawrence…
RBCC & Therakine Initiate Phase II of Revolutionary Delivery Technology
Rainbow Coral Corp. and its joint venture partner, Therakine, Ltd., recently announced they have reached a major new milestone in the development of a revolutionary…
Cardiovascular Disease Market: US to Lead Modest Growth; Electronic Cigarettes Could Be the Next Blockbuster
The global market for Cardiovascular Disease (CVD) - composed of Heart Failure (HF), Myocardial Infarction (MI), and Acute Coronary Syndrome (ACS) - is expected to…
Kytosan USA Looks to Become Market Leader for Domestic Chitosan
Under an exclusive patent licensing agreement from its parent, KYTOSAN USA will produce and market high-quality industrial-grade chitosan, a specialty chemical made from discarded crustacean…
Unilife Announces Clinical Supply Agreement With Novartis
Unilife recently announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one…
Hovione’s New Inhalation Capsule Filling Machine Fills Market Gap
Hovione recently announced the expansion of its inhalation drug product development services with the introduction of a high-precision MG2 FlexaLAB capsule filling machine. This investment…
The Three Big Predictions for the Global Healthcare Market
Frost & Sullivan recently released its three big predictions for the global healthcare market. Based on a 2013 Search for Growth survey that involved 1835…
Foster Introduces Online Polymer Purchases for Medical Device Product Development
Foster Polymer Distribution, a business unit of Foster Corporation that specializes in distribution of medical grade polymers, recently announced the introduction of a new website…
Ganymed Pharmaceuticals Closes Significant Financing Round
Ganymed Pharmaceuticals AG, a biopharmaceutical company developing highly selective Ideal Monoclonal Antibodies (IMABs) for the treatment of cancer, recently announced the completion of a EUR…
Avalon Ventures-GlaxoSmithKline Launch Sitari Pharm
Avalon Ventures recently announced the launch of Sitari Pharmaceuticals, the first company formed by Avalon and GlaxoSmithKline (GSK) under a unique collaboration recently established to…
Alnylam Earns $7 Million Milestone Payment from Genzyme
Alnylam Pharmaceuticals, Inc. recently announced it has earned a $7-million milestone from its partner Genzyme, a Sanofi company, for achieving Phase II success with patisiran…
IBM Research & Institute of Bioengineering & Nanotechnology Discover Breakthrough for Breast Cancer Delivery
Recently, scientists from IBM and Singapore's Institute of Bioengineering and Nanotechnology published a breakthrough drug delivery technique, demonstrating the first biodegradable, biocompatible, and non-toxic hydrogel…
Aquavit Pharmaceuticals Adds Advanced Delivery Technology to Portfolio
Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding preliminary agreement with Huons Co, Ltd., a leading Korean pharmaceuticals…
Egalet, Shionogi Sign $425-Million Plus Deal
Egalet Corporation recently announced it has entered into a definitive collaboration and license agreement with Shionogi Limited for the development and potential commercialization of multiple…
Oramed Pharmaceuticals Receives Patent for the Oral Delivery of Insulin
Oramed Pharmaceuticals Inc. recently announced that the European Patent Office has allowed the company's patent for its invention, titled Methods and Compositions for Oral Administrations…
Rapid Delivery Program Product Portfolio Expands to Biopharmaceutical Injectable Market
BD Medical recently announced the BD Accelerate program now offers a solution for the biopharmaceutical injectable drug market with the BD Neopak Glass Prefillable Syringe…
